SAN DIEGO, Jan. 21, 2026 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global leader of in vitro diagnostics, announced today that it will report its financial results for the fourth quarter and full year 2025 ended December 28, 2025, after the…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
